MedTrace Logo

Does Meloxicam Provide as Much Pain Relief as Opioids After Shoulder Surgery?

NCT04725357 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2021-01-26

No results posted yet for this study

Summary

The opioid epidemic continues to be a major concern, with orthopedic surgeons being among the top prescribers of opioids. Studies evaluating these practices found that opioids are overprescribed, even for common procedures. Patients undergoing arthroscopic labrum repair of the shoulder were found to have an average of 20 pills left over after surgery. Many strategies have been developed to tackle overprescribing and have found success, including no opioid protocols for carpal tunnel release. The purpose of this study is to examine if meloxicam alone provides similar patient reported outcomes to opioids following arthroscopic labrum repair of the shoulder.

Conditions

  • Shoulder Pain

Interventions

DRUG

Meloxicam 15 mg

Participants will receive a prescription of 20 pills of 15 mg Meloxicam after surgery

PROCEDURE

Preoperative Interscalene Nerve Block

Preoperatively participants will standardly receive an interscalene nerve block

PROCEDURE

arthroscopic labral repair

participant will have their standard surgical procedure done

Sponsors & Collaborators

  • Rothman Institute Orthopaedics

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-25
Primary Completion
2022-01-25
Completion
2022-01-25
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04725357 on ClinicalTrials.gov